Researchers discover new therapeutic approach for cardiorenal syndrome type 2

Posted by on June 14, 2016 12:33 pm
Categories: health

A study suggests a new therapeutic approach to treat the development of chronic kidney disease secondary to chronic heart failure, known as cardiorenal syndrome type 2. Researchers suggest inhibiting G protein-coupled receptors (GPCR) could prevent renal damage in cardiorenal syndrome type 2 (CRS2), and could also prevent acute kidney injury (AKI).

Leave a Reply

Your email address will not be published. Required fields are marked *